| Assay ID | Title | Year | Journal | Article |
|---|
| AID1206983 | Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 10 uM after 72 hrs by sulforhodamine B assay relative to control | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID1206985 | Cytotoxicity against human NUGC3 cells assessed as cell viability at 10 uM after 72 hrs by sulforhodamine B assay relative to control | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID1206994 | Inhibition of NF-kappaB (unknown origin) transcriptional activity in LPS-induced mouse RAW264.7 cells after 1 hr by secreted alkaline phosphatase assay | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID1303063 | Inhibition of LPS-induced NFkappaB (unknown origin) transcriptional activity expressed in mouse RAW264.7 cells at 100 uM incubated for 16 hrs by SEAP based reporter gene assay relative to control | 2016 | ACS medicinal chemistry letters, Apr-14, Volume: 7, Issue:4
| Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents. |
| AID1142756 | Cytotoxicity against human NCI-H23 cells assessed as growth inhibition after 72 hrs by SRB assay | 2014 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 24, Issue:11
| Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors. |
| AID1766326 | Inhibition of NF-kappaB transcriptional activity in mouse RAW264.7 cells harbouring NF-kappaB-SEAP-NPT reporter plasmid assessed as reduction in LPS-induced SEAP expression incubated for 16 hr with LPS | 2021 | Bioorganic & medicinal chemistry, 09-15, Volume: 46 | Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway. |
| AID1206981 | Cytotoxicity against human ACHN cells assessed as cell viability at 10 uM after 72 hrs by sulforhodamine B assay relative to control | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID1303064 | Inhibition of LPS-induced NFkappaB (unknown origin) transcriptional activity expressed in mouse RAW264.7 cells incubated for 16 hrs by SEAP based reporter gene assay | 2016 | ACS medicinal chemistry letters, Apr-14, Volume: 7, Issue:4
| Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents. |
| AID494675 | Inhibition of LPS-induced NF-kappaB transcriptional activity in mouse RAW264.7 cells | 2010 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
| Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives. |
| AID1206986 | Cytotoxicity against human PC3 cells assessed as cell viability at 10 uM after 72 hrs by sulforhodamine B assay relative to control | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID1206984 | Cytotoxicity against human NCI-H23 cells assessed as cell viability at 10 uM after 72 hrs by sulforhodamine B assay relative to control | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID247976 | Inhibition concentration against DPPH radical scavenging activity in rat was determined | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and evaluation of 6-hydroxy-7-methoxy-4-chromanone- and chroman-2-carboxamides as antioxidants. |
| AID494674 | Inhibition of LPS-induced NF-kappaB transcriptional activity in mouse RAW264.7 cells at 100 uM | 2010 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
| Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives. |
| AID248540 | Inhibition concentration against lipid peroxidation initiated by [Fe2+] and L-ascorbic acid in rat brain homogenates | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and evaluation of 6-hydroxy-7-methoxy-4-chromanone- and chroman-2-carboxamides as antioxidants. |
| AID1206982 | Cytotoxicity against human HCT15 cells assessed as cell viability at 10 uM after 72 hrs by sulforhodamine B assay relative to control | 2015 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
| Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. |
| AID494676 | Cytotoxicity against human NCI-H23 cells | 2010 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
| Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives. |
| AID1142758 | Inhibition of transcriptional activity of NF-kappaB (unknown origin) transfected in LPS-stimulated mouse RAW264.7 cells after 16 hrs by secretory alkaline phosphatase reporter gene assay | 2014 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 24, Issue:11
| Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |